Testing a new non-surgical prostate cancer treatment
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new, non-surgical treatment called irreversible electroporation (IRE) for men with early-stage prostate cancer that hasn't spread. It uses short electrical pulses to destroy cancer cells while sparing healthy tissue nearby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 40 and 85 years old.
- You have a visible tumor on an MRI scan.
- Your cancer is localized (not spread) and has a low or intermediate Gleason score (7 or less), PSA of 20 or less, and stage T2 or less.
- You are able to have an MRI with contrast dye.
- You do not have an active urinary tract infection, bladder stone, bladder cancer, urethral stricture, or neurogenic bladder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new focal treatment called IRE (irreversible electroporation) that uses electrical pulses to destroy prostate cancer cells while sparing healthy tissue. It is for men with intermediate-risk prostate cancer that has not spread outside the prostate gland.
This study tests a new technique called irreversible electroporation (IRE) for treating pelvic tumors that have returned despite earlier treatment. IRE uses electrical pulses to destroy cancer cells without surgery, offering a potential option when other local treatments like surgery or radiation are not suitable.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This trial tests a new imaging method that uses sound waves to check the accuracy of proton radiation therapy for prostate cancer. It aims to improve treatment precision while being non-invasive, and participants will need to tolerate a water-filled ultrasound pad on their skin during treatment.
This trial uses advanced MRI scans and detailed tissue analysis to better detect prostate cancer. It is for people with confirmed prostate cancer who are already scheduled for prostate removal surgery.
This study uses a special kind of MRI to better “map” prostate cancer inside the prostate. Researchers compare the MRI results with the detailed tissue exam after prostate surgery to see how accurate the imaging is.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.